Pay in 4 interest-free payments of $6.62 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
4 BaarM
| Peptide | Dose | Route | Frequency | Cycle Length | |---|---|---|---|---| | CJC-1295 (non-DAC) | 100-200 mcg | Subcutaneous | 2-3x/day | 8-12 weeks | | CJC-1295 (DAC) | 1-2 mg | Subcutaneous | 1-2x/week | 8-12 weeks | | Epitalon | 5-10 mg | Subcutaneous | Daily | 10-20 days, 1-2x/year | Safety Profile and Known Adverse Effects Neither peptide carries an FDA approval, meaning long-term safety data from large controlled trials is absent
J.McCoyW
Miura, T
Scaglione, Francesco, and Giscardo Panzavolta
Pollard, J
US$ 20.88
US$ 23.73
US$ 28.51
US$ 23.09
